Home
Careers
Conferences
Directory
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Pharmaceutical Market Trends, 2008 - 2012: key market forecasts & growth opportunities
2.
Top-10 Biotech Companies - Market Outlook, 2008-2023
3.
Competitor Analysis: Janus Kinase (JAK) Inhibitors
4.
Enzyme Replacement & Enhancement Therapies (ERT)
5.
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6.
The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
7.
Protein Therapeutics Markets
8.
European Clinical Trial Site Options: An Insiders Analysis Overview
9.
Quality for Biologics
10.
Mammography World Markets
Best Sellers:
1.
Contract Research Annual Review 2008
2.
The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
3.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
4.
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts The challenge of turning technology into therapy
5.
Orthopedics - Global Industry Guide
6.
Competitor Analysis: c-MET/HGF Inhibitors
7.
Competitor Analysis: Alzheimers Disease Antibodies
The Global Protein Therapeutics Market
The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently available in the category. Recombinant proteins are potentially advantageous in terms of higher efficacy and fewer side effects than other pharmaceutical products, as they can be more specifically targeted to the cause of the disease, rather than the treatment of its symptoms.
This report examines each of the protein therapeutics classes in turn, assessing the market potential, and encompassing main therapeutic areas to which they are applicable.
The following product classes are analyzed in this report:
erythropoietins (EPO)
interferons
interleukins
insulin
monoclonal antibodies
blood-clotting factors
colony-stimulating factors (CSFs)
growth hormones
plasminogen activators
reproductive hormones
therapeutic enzymes
The report assesses the overall protein therapeutics market, key classes, and the factors influencing their historical and future performance. The report provides an overview of key products in each category, comparing their clinical efficacy and marketing position. The overview of the current market is given in terms of segmentation by category, by region and by leading players and their products. Moreover, the report examines the promise of new drugs in each class and research and development efforts aimed at improving their delivery.
Finally, the future performance of the protein therapeutics market as a whole is examined against the background of pricing, emerging generic competition and manufacturing issues, indicating the likely trends in the coming years, and identifying possible solutions for problematic issues.
Key Features of this report:
Overview of the protein therapeutics environment, including main therapeutic categories, drug delivery technologies and key players
In-depth analysis of different classes of protein therapeutics, including key drugs in major therapeutic areas, as well as their advantages and disadvantages
Comprehensive facts and figures for the protein therapeutics market, including main players and regional break-downs
Future trends in the protein therapeutics marketplace, shaped by medical and technological advances as well as demographic and epidemiological changes and industry needs
Outlook for the protein therapeutics market, including manufacturing considerations and research into new methods of protein delivery
Publication Date: December 7, 2006
Pages: 348 Format PDF
Table of Contents
Price
Single User PDF $3250.00
Site Licence PDF $4599.00
Corporate Wide Licence PDF $6999.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.